(02) 9926 4726

News and Event

Realising The Role of Basic Science in Translational Research Centres: Are We There Yet?

A presentation about support the goals of the following groups who are affiliated to a NSW Translational Cancer Research Centre (TCRC): Basic researchers, T2-T4 researchers
clinicians and community of practice members with an interest in the translational pipeline.

Workshop held on 17 May 2017 


Read more

Asbestos 101

We’re sure you have heard of asbestos. It’s a highly heat-resistant fibrous mineral that is found in some fabrics, brake linings and fire-resistant and insulating materials.

Read more

Scalp Cooling – What Is It?

Chemotherapy induced hair-loss can be very demotivating, distressing and it knocks the confidence of many who have to go through it.

Read more

What is Translational Cancer Research?

Cancer research is one of the most talked about topics and rightly so. Cancer research is making incredible breakthroughs and paving the way for a future where cancer can be cured and prevented.

Read more

Research Scholarship Awards – Round 5

Sydney Vital is pleased to announce the awardees for round 5 of our research scholarships awards. Congratulations to all our awardees and those who applied.

Read more

Research Fellowship in the area of Nanotechnology – CLOSED

Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.

This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.

Key Dates

Call for Applications: Tuesday 31st January 2017
Closing Date for Applications: Tuesday 27th February 2017
Announcement of Outcome aim at: Wednesday 15th March 2017
Please read on: Flagship3_ Nanotechnology_Research Fellowship_ Application_2017-31012017

Please let us know if you have any further questions.

Email: [email protected] for general information regarding your application submission.

Email: Alexander Engel: [email protected] for specific question regarding the Flagship 3.

Read more

Sydney Vital Cancer Conference 2016

The Sydney Vital Centre Conference 2016 (SCVV 2016) saw a panel of medical specialists, patient advocates and patients gather at the Kolling Institute to discuss how cancer research improves outcomes.

Read more

Research Scholarship Applications Round 5 – CLOSED

Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $10,000 each for one year, to students, preclinical and clinical researchers working in the area of Translational Cancer Research.

Read more

Funding Awarded By Sydney Vital

The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.

#AwardeeInstitutionSupervisorResearch TitleAmount
1Jerikho BulanadiKolling Institute of Medical ResearchProf Ross SmithChemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.$15,000
2Emma ColvillSydney University Medical SchoolProf Paul KeallThe bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer$15,000
3Grace GiffordHaematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, SydneyDr William StevensonGene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.$15,000
4Dr Anthony GloverKolling Institute of Medical Research, Royal North Shore HospitalProf Stanley SidhuNoncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.$15,000
5Diana HatoumFaculty of Science, UTS SydneyDr Najah NassifA Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.$15,000
6Samuel BrennanFaculty of Science, UTS SydneyDr Rose Martiniello-WilksDevelopment of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.$15,000
7Ben HarrisSydney Medical School, University of SydneyDr Kellie CharlesInvestigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.
8Adrian LeeBill Walsh Translation Cancer Research Laboratory, Kolling InstituteDr Viive Howell"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with
glioblastoma multiforme?"
9Jaynish ShahSydney Medical School, University of SydneyProf Deborah MarshInvestigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?$15,000
Read more

Resistance to Therapy Pillar 3 Function – CLOSED

We are excited to start 2016 with a new networking opportunity for researchers (scientists and clinicians) interested in the Resistance to Therapy Pillar. We are planning a series of meetings/seminars/collaborative discussions over the coming year.

If you are interested in cancer resistance mechanisms, drug or antibody resistance pathways, predictors of disease recurrence/relapse or clinical data sets with samples for testing for recurrence, please complete the following quick 5 question survey.

We hope that you will join us for our first networking function at the Urban Hotel, St Leonards on March 22nd March at 6:30pm. This will be an informal introduction dinner with speedy 3 min summary of your research field and priorities. If you are interested in attending this function, please RSVP to [email protected].

Best regards,

Debbie Marsh, Kellie Charles, Connie Diakos and Mustafa Khasraw (Pillar 3 Resistance to Therapy Pillar Co-leads).


Read more